Abstract
Progressive loss in dopaminergic neurons (DA) of substantia nigra pars compacta (SNc) leads to Parkinson’s disease with a hypothesis of oxidative stress generation. The present study was conducted to determine the long-term efficacy of silymarin (SM) post-treatment on 6-OHDA–induced oxidative stress in the SNc of male rats. Male Wistar rats were received 6-OHDA (8 μg/rat) into SNc. After 3 weeks, as recovery period, the animals were treated with i.p. injection of SM at different doses of 100, 200, or 300 mg/kg for 15 days. At the end of the treatment, motor function, neuronal cell count, antioxidant enzymes, and lipid peroxidation and tyrosine hydroxylase (TH) activities were evaluated in the ventral midbrain tissue. The 6-OHDA significantly decreased (p ≤ 0.05) motor function, antioxidant enzyme activity, GSH level, and GSH/GSSG ratio and caused an augmentation in GSSG and lipid peroxidation level. The 6-OHDA also reduced the population of neurons and TH expression. The SM repaired the 6-OHDA–induced motor impairment, antioxidant enzyme suppression, and TH down-regulation. All three doses of SM could restore the MDA level to the normal range in the 6-OHDA–lesioned rats and could reversed the effect of 6-OHDA on GSH, GSSG level, and GSH/GSSG ratio. The SM treatment significantly and dose-dependently increased (p ≤ 0.001) the total number of surviving neurons in the SNc. Silymarin chronic treatment restored the brain’s antioxidant capacity and salvaged neurons from oxidative stress-induced neurodegeneration. The SM could also improve motor function in parkinsonian animals by increasing TH expression. These results recommend that application of SM over initial clinical stages may depict a hopeful approach versus PD. However, more research is needed to confirm this issue.
Similar content being viewed by others
Change history
15 December 2023
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1007/s00210-023-02898-4
References
Alam Z, Jenner A, Daniel S, Lees A, Cairns N, Marsden C, Jenner P, Halliwell B (1997) Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem 69:1196–1203
Andersen JK (2004) Oxidative stress in neurodegeneration: cause or consequence? Nat Med 10:S18–S25
Boix J, von Hieber D, Connor B (2018) Gait analysis for early detection of motor symptoms in the 6-OHDA rat model of Parkinson's disease. Front Behav Neurosci 12:39
Bonda DJ, Wang X, Perry G, Nunomura A, Tabaton M, Zhu X, Smith MA (2010) Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology 59:290–294
Chen L, Cheng L, Wei X, Yuan Z, Wu Y, Wang S, Ren Z, Liu X, Liu H (2017a) Tetramethylpyrazine analogue CXC195 protects against dopaminergic neuronal apoptosis via activation of PI3K/Akt/GSK3β signaling pathway in 6-OHDA-induced Parkinson’s disease mice. Neurochem Res 42:1141–1150
Chen Y, Lian Y, Ma Y, Wu C, Zheng Y, Xie N (2017b) The expression and significance of tyrosine hydroxylase in the brain tissue of Parkinson's disease rats. Exp Ther Med 14:4813–4816
Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39:889–909
Deumens R, Blokland A, Prickaerts J (2002) Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175:303–317
El-Awady E-SE, Moustafa YM, Abo-Elmatty DM, Radwan A (2011) Cisplatin-induced cardiotoxicity: mechanisms and cardioprotective strategies. Eur J Pharmacol 650:335–341
El-Shitany NA, El-Haggar S, El-Desoky K (2008) Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats. Food Chem Toxicol 46:2422–2428
Floyd RA (1999) Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 222:236–245
Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM-Y (2000) Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions. Science 290:985–989
Haddadi R, Nayebi AM, Brooshghalan SE (2013) Pre-treatment with silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats. Neurosci Lett 555:106–111
Haddadi R, Nayebi AM, Brooshghalan SE (2018a) Silymarin prevents apoptosis through inhibiting the Bax/caspase-3 expression and suppresses toll like receptor-4 pathway in the SNc of 6-OHDA intoxicated rats. Biomed Pharmacother 104:127–136
Haddadi R, Poursina M, Zeraati F, Nadi F (2018b) Gastrodin microinjection suppresses 6-OHDA-induced motor impairments in parkinsonian rats: insights into oxidative balance and microglial activation in SNc. Inflammopharmacology 26:1305–1316
Haleagrahara N, Siew CJ, Mitra NK, Kumari M (2011) Neuroprotective effect of bioflavonoid quercetin in 6-hydroxydopamine-induced oxidative stress biomarkers in the rat striatum. Neurosci Lett 500:139–143
Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97:1634–1658
Jenner P (2003) Oxidative stress in Parkinson's disease. Ann Neurol 53:S26–S38
Kheradmand A, Nayebi AM, Jorjani M, Khalifeh S, Haddadi R (2016) Effects of WR1065 on 6-hydroxydopamine-induced motor imbalance: possible involvement of oxidative stress and inflammatory cytokines. Neurosci Lett 627:7–12
Liang Q, Liou AK, Ding Y, Cao G, Xiao X, Perez RG, Chen J (2004) 6-hydroxydopamine induces dopaminergic cell degeneration via a caspase-9-mediated apoptotic pathway that is attenuated by caspase-9dn expression. J Neurosci Res 77:747–761
Liang J-q, Wang L, He J-c, X-d H (2016) Verbascoside promotes the regeneration of tyrosine hydroxylase-immunoreactive neurons in the substantia nigra. Neural Regen Res 11:101
Martí MJ, Saura J, Burke RE, Jackson-Lewis V, Jiménez A, Bonastre M, Tolosa E (2002) Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat. Brain Res 958:185–191
Mazzio EA, Reams RR, Soliman KF (2004) The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro. Brain Res 1004:29–44
Morroni F, Tarozzi A, Sita G, Bolondi C, Moraga JMZ, Cantelli-Forti G, Hrelia P (2013) Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease. Neurotoxicology 36:63–71
Narbute K, Piļipenko V, Pupure J, Dzirkale Z, Jonavičė U, Tunaitis V, Kriaučiūnaitė K, Jarmalavičiūtė A, Jansone B, Kluša V (2019) Intranasal administration of extracellular vesicles derived from human teeth stem cells improves motor symptoms and normalizes tyrosine hydroxylase expression in the substantia nigra and striatum of the 6-hydroxydopamine-treated rats. Stem Cells Transl Med 8:490–499
Nencini C, Giorgi G, Micheli L (2007) Protective effect of silymarin on oxidative stress in rat brain. Phytomedicine 14:129–135
Owen AD, Schapira AH, Jenner P, Marsden CD (1996) Oxidative stress and Parkinson's disease. Ann N Y Acad Sci 786:217–223
Paxinos G, Watson C (2006) The rat brain in stereotaxic coordinates, hard cover edn. Elsevier, Amsterdam
Petithomme Feve A (2012) Current status of tyrosine hydroxylase in management of Parkinson's disease. CNS Neurol Disord Drug Targets 11:450–455
Radko L, Cybulski W (2007) Application of silymarin in human and animal medicine. J Pre-Clin Clin Res 1(1):22–26
Raza SS, Khan MM, Ashafaq M, Ahmad A, Khuwaja G, Khan A, Siddiqui MS, Safhi MM, Islam F (2011) Silymarin protects neurons from oxidative stress associated damages in focal cerebral ischemia: a behavioral, biochemical and immunohistological study in Wistar rats. J Neurol Sci 309:45–54
Schwarting R, Huston J (1996) The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog Neurobiol 50:275–331
Shulman JM, De Jager PL, Feany MB (2011) Parkinson's disease: genetics and pathogenesis. Annu Rev Pathol 6:193–222
Stadtman ER (2002) Importance of individuality in oxidative stress and aging. Free Radic Biol Med 33:597–604
Tsai M-J, Liao J-F, Lin D-Y, Huang M-C, Liou D-Y, Yang H-C, Lee H-J, Chen Y-T, Chi C-W, Huang W-C (2010) Silymarin protects spinal cord and cortical cells against oxidative stress and lipopolysaccharide stimulation. Neurochem Int 57:867–875
Zhou M, Zhang W, Chang J, Wang J, Zheng W, Yang Y, Wen P, Li M, Xiao H (2015) Gait analysis in three different 6-hydroxydopamine rat models of Parkinson's disease. Neurosci Lett 584:184–189
Acknowledgments
The authors would like to thank the Research and Technology Vice-Chancellor of Hamadan University of Medical Sciences (Hamadan, Iran) for financial support of this study (grant no.: 950207475).
Author information
Authors and Affiliations
Contributions
RH, the supervisor of the study, was involved in the concept, design, and support of the study and drafting and final checking of the manuscript. SEB carried out the statistical analyses and drafting. AMN participated and involved in the interpretation of data and final check of the draft and helped to revise the manuscript. MS involved in doing biochemical analyses and drafting. SAA involved in doing preparation of histological slides and biochemical analyses and drafting. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interests
The authors declare that they have no potential conflict of interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article has been retracted. Please see the retraction notice for more detail:https://doi.org/10.1007/s00210-023-02898-4
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Haddadi, R., Eyvari-Brooshghalan, S., Nayebi, A.M. et al. RETRACTED ARTICLE: Neuronal degeneration and oxidative stress in the SNc of 6-OHDA intoxicated rats; improving role of silymarin long-term treatment. Naunyn-Schmiedeberg's Arch Pharmacol 393, 2427–2437 (2020). https://doi.org/10.1007/s00210-020-01954-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-020-01954-7